Lab Sciences
Top stories summarized by our editors
9/14/2018

Egypt is planning a massive hepatitis C screening initiative from October to April with the goal of testing 50 million citizens. The World Health Organization has said Egypt has highest prevalence of HCV globally, and an estimated 10% of people ages 15 to 59 have the virus.

Full Story:
Ahram Online (Egypt)
9/13/2018

The American Heart Association and the Inter-American Society of Cardiology said in the journal Circulation that health care providers should be prepared to recognize, diagnose and treat Chagas' disease outside areas where it is traditionally endemic. "Early detection of Chagas' disease is critical, allowing prompt initiation of therapy when the evidence for cure is strong," said co-author Dr. Caryn Bern of the University of California at San Francisco.

9/13/2018

Blood banks are seeking supplies for areas that could be affected by Hurricane Florence, and some hospitals are moving patients out of coastal areas and preparing for power outages and increased casualties. HHS has declared a public health emergency in South Carolina, North Carolina and Virginia.

9/13/2018

A six-week study in the Journal of the International AIDS Society of low-dose aspirin taken once a day was associated with reductions in levels of HIV target cells among seronegative women in Kenya.

Full Story:
MD Magazine online
9/12/2018

A federal appeals court ruling upheld a 2014 decision that awarded the first CRISPR-Cas9 patent to the Broad Institute of MIT and Harvard. A statement from the Broad Institute spoke of moving "beyond litigation" and working together to provide "open access to this transformative technology."

Full Story:
Xconomy
9/11/2018

The FDA said it is taking steps to strengthen its oversight of medical device cybersecurity and already working on much of what a new report from the HHS Office of Inspector General recommends. The report called for the FDA to consistently address cybersecurity earlier in the approval process, add cybersecurity in its refuse-to-accept checklist and integrate it into digital templates for evaluation of lower-risk devices.

9/11/2018

A study suggests testing for plasma kidney injury molecule-1 concentrations could help spot renal cell carcinoma up to five years prior to clinical diagnosis. The study found patients who developed renal cell carcinoma within a five-year period had twice the concentration of kidney injury molecule-1 in prediagnostic plasma.

More Summaries:
kidney cancer
9/11/2018

Several professional groups have published an international guideline for clinicians on evaluating and diagnosing women with polycystic ovary syndrome. The guideline suggests use of extraction chromatography immunoassays and liquid chromatography-mass spectrometry to evaluate free testosterone levels in women suspected of having PCOS, and it recommends against use of anti-Mullerian hormone for diagnosing hyperandrogenism until there are more data.

9/11/2018

South Korea's SCM Lifescience raised $35 million to support the development of mesenchymal stem cell therapies, including trials of therapy candidates for chronic and acute graft-versus-host disease.

Full Story:
BioCentury
9/10/2018

The University of North Carolina at Chapel Hill HIV Cure Center and Cell Microsystems will use a $283,000 NIH grant to develop a platform for automatically quantifying HIV in latent reservoirs.